Deborah A. Buffington, B.S., Chief Operating Officer of Innovative BioTherapies, Inc. Ms. Buffington holds a bachelors of science degree in Biology from the University of Michigan. She co-discovered many of IBT’s proprietary processes and co-authored many of the critical publications on the subject of tissue engineering a bioartificial kidney. Along with Dr. Humes, she co-holds several of the Company's key patents. Ms. Buffington was previously associated with the University of Michigan and the VA Medical Center. She was the Director of Research and Production Activities at Nephros Therapeutics, where she facilitated the successful submission of an IND to the FDA for clinical trial testing of a cell-based device for the treatment of acute renal failure. In 2005, she joined Innovative BioTherapies, Inc., as Vice President of Business & Research Operations. In an ongoing effort to advance IBT’s lead technologies, she has secured two SBIR Phase I grants, one SBIR Phase II grant and is co-PI on a cooperative research agreement from the U.S. Department of Defense.

 Bioartificial kidney